Ignite Creation Date:
2025-12-25 @ 4:04 AM
Ignite Modification Date:
2025-12-26 @ 3:00 AM
Study NCT ID:
NCT01321502
Status:
COMPLETED
Last Update Posted:
2018-01-23
First Post:
2011-03-21
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Bioequivalency Study of Famciclovir 500 mg Tablets Under Fed Conditions
Sponsor:
Roxane Laboratories
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
FAMC-T500-PVFD-1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Elizabeth Ernst, Executive Director, Drug Regulatory and Medical Affairs
Old Organization:
Roxane Laboratories, Inc.